Exhibit 99.1
Contacts: | Steven O. Cordier |
Sr. Vice President and CFO
(303) 649-1900
scordier@penx.com
PENFORD REPORTS SECOND QUARTER FISCAL YEAR 2014 FINANCIAL RESULTS
| • | Second quarter operating income rose 15% to $2.9 million from last year’s second quarter. |
| • | Second quarter gross margin increased 11% to $12.2 million. |
| • | Food Ingredients quarterly sales rose 14% to a record of $30.3 million. |
| • | Gum Technology Corporation was acquired on March 25, 2014. |
CENTENNIAL, CO, April 9, 2014 – Penford Corporation (Nasdaq: PENX), a leader in ingredient systems for food and industrial markets, today reported second quarter and year-to-date fiscal year 2014 results.
The Company reported net income of $1.2 million, or $0.10 per diluted share, for the quarter. Consolidated sales for the quarter were $106 million compared with $110 million in last year’s second quarter, primarily because lower corn and by-product prices reduced revenues. Gross margins improved in both divisions despite the difficult winter manufacturing situation. Consolidated operating income increased 15% on higher volumes, better results from ethanol operations and an improving total product mix.
In the first half of fiscal 2014, consolidated sales were $215.4 million and net income equaled $1.7 million, or $0.13 per diluted share.
| | | | | | | | | | | | |
Penford Corporation - Financial Highlights | | | | | | | | | |
| | | |
(In thousands) | | Q2 FY 14 | | | Q1 FY 14 | | | Q2 FY 13 | |
Food Ingredients: | | | | | | | | | | | | |
Sales | | $ | 30,279 | | | $ | 28,651 | | | $ | 26,604 | |
Gross Margin | | | 8,813 | | | | 9,274 | | | | 8,128 | |
EBITDA (see note below) | | | 6,316 | | | | 7,055 | | | | 6,082 | |
Industrial Ingredients: | | | | | | | | | | | | |
Sales | | $ | 75,828 | | | $ | 80,600 | | | $ | 83,478 | |
Gross Margin | | | 3,356 | | | | 1,435 | | | | 2,873 | |
EBITDA (see note below) | | | 2,726 | | | | 647 | | | | 2,342 | |
Consolidated: | | | | | | | | | | | | |
Sales | | $ | 106,107 | | | $ | 109,251 | | | $ | 110,082 | |
Gross Margin | | | 12,169 | | | | 10,709 | | | | 11,001 | |
EBITDA (see note below) | | | 6,225 | | | | 4,940 | | | | 6,037 | |
Net income | | | 1,240 | | | | 488 | | | | 1,191 | |
| | | | | | | | |
Consolidated: | | LTM Feb ‘14 | | | LTM Feb ‘13 | |
Sales | | $ | 454,503 | | | $ | 449,610 | |
EBITDA (see note below) | | | 20,694 | | | | 17,945 | |
Net income (loss) | | | 2,837 | | | | (6,921 | ) |
Total Debt | | | 68,900 | | | | 85,632 | |
Highlights for the quarter are as follows:
Food Ingredients Division
| • | | Revenues increased on stronger volumes in nearly every product segment, including pet products, gluten-free, sauces, protein and coating applications. |
| • | | Additional investments in R&D and commercial staff increased operating expenses by about 15% in each category. |
| • | | Operating income improved to $5.8 million on higher sales and higher plant capacity utilization. |
Industrial Ingredients Division
| • | | Revenue declined 9% to $75.8 million on lower prices for corn and by-products. Unit prices, excluding corn, increased. |
| • | | Bio-products revenue was up 20% on improved volumes largely from new business gains. |
| • | | The Company increased ethanol volumes more than 30% as crush margins expanded on higher demand and fuel market supply chain dislocations that caused regional shortages during the harsh winter. |
| • | | Gross margin rose 17% on higher volumes, lower input costs and higher plant through-put despite challenging production conditions that pushed energy, freight and maintenance costs up by more than $1 million above a year ago. |
| • | | Operating income was slightly above break-even compared with a loss of $0.5 million in the second quarter last year. |
Consolidated Results
| • | | Cash use from operations was $3.3 million less than a year ago primarily due to lower working capital balances. |
| • | | Total debt outstanding fell $16.7 million, or 20%, to $68.9 million from a year ago. |
Acquisition Details
| • | | On March 25, 2014, the Company acquired Gum Technology, which markets a wide range of gums and other hydrocolloids. |
| • | | The combination should create growth opportunities through applications development in both the food and industrial businesses. |
| • | | The Company expects the acquisition to be accretive within the next twelve months. |
Conference Call
The Company will host a conference call to discuss fiscal 2014 second quarter results today, April 9, 2014 at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time). Access information for the call and web-cast can be found atwww.penx.com. To participate in the call on April 9, 2014, please phone 1-877-407-9205 at 7:50 a.m. Mountain Time. A replay will be available atwww.penx.com.
About Penford Corporation
Penford Corporation develops, manufactures and markets specialty, natural-based ingredient systems for a variety of food and industrial products. Penford operates six manufacturing facilities and three research and development centers in the United States.
The statements contained in this release that are not historical facts are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as “believes,” “may,” “will,” “looks,” “should,” “could,” “anticipates,” “expects,” or comparable terminology or by discussions of strategies or trends. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly affect expected results. Actual future results could differ materially from those described in such forward-looking statements, and the Company does not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that could cause actual results to differ materially are the risks and uncertainties discussed in this release and those described from time to time in other filings with the Securities and Exchange Commission which include, but are not limited to: competition; the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors; product development risk; changes in corn and other raw material prices and availability; the Company’s inability to comply with the terms of instruments governing the Company’s debt; changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company’s products, including changes in government rules or incentives affecting ethanol consumption, unfavorable shifts in product mix; unanticipated costs, expenses or third party claims; impairment of the Company’s long-lived assets that could result in a noncash charge to reported earnings; interest rate, chemical and energy cost volatility; changes in returns on pension plan assets and/or assumptions used for determining employee benefit expense and obligations; unforeseen developments in the industries in which Penford operates; and other factors described in the “Risk Factors” section in reports filed with the Securities and Exchange Commission.
# # #
CHARTS TO FOLLOW
2
| | | | | | | | | | | | | | | | |
Penford Corporation Financial Highlights | | Three Months Ended February 28, | | | Six Months Ended February 28, | |
(In thousands, except per share data) | | 2014 | | | 2013 | | | 2014 | | | 2013 | |
Consolidated Results (unaudited) | |
Sales | | $ | 106,107 | | | $ | 110,082 | | | $ | 215,357 | | | $ | 228,104 | |
| | | | |
Income from operations | | $ | 2,911 | | | $ | 2,530 | | | $ | 4,552 | | | $ | 6,550 | |
| | | | |
Net income | | $ | 1,240 | | | $ | 1,191 | | | $ | 1,727 | | | $ | 2,897 | |
| | | | |
Earnings per share, diluted | | $ | 0.10 | | | $ | 0.10 | | | $ | 0.13 | | | $ | 0.23 | |
|
Cash Flows (unaudited) | |
Cash flow provided by (used in): | | | | | | | | | | | | | | | | |
Operating activities | | $ | (283 | ) | | $ | (3,592 | ) | | $ | 8,391 | | | $ | 3,352 | |
Investing activities | | | (3,158 | ) | | | (1,565 | ) | | | (5,477 | ) | | | (4,990 | ) |
| | | | |
Financing activities | | | 3,244 | | | | 5,186 | | | | (3,135 | ) | | | 1,634 | |
| | | | | | | | | | | | | | | | |
Increase/(decrease) in cash | | $ | (197 | ) | | $ | 29 | | | $ | (221 | ) | | $ | (4 | ) |
| | | | | | | | |
Balance Sheets (unaudited) | |
| | February 28, 2014 | | | August 31, 2013 | |
Current assets | | $ | 89,793 | | | $ | 90,114 | |
Property, plant and equipment, net | | | 111,519 | | | | 112,141 | |
Other assets | | | 21,121 | | | | 22,363 | |
| | | | | | | | |
Total assets | | | 222,433 | | | | 224,618 | |
| | | | | | | | |
| | |
Current liabilities | | | 36,885 | | | | 35,640 | |
Long-term debt | | | 67,597 | | | | 72,739 | |
Other liabilities | | | 33,001 | | | | 33,346 | |
Shareholders’ equity | | | 84,950 | | | | 82,893 | |
| | | | | | | | |
Total liabilities and equity | | $ | 222,433 | | | $ | 224,618 | |
| | | | | | | | |
3
Penford Corporation
| | | | | | | | | | | | | | | | |
Consolidated Statements of Operations (unaudited) | | Three Months Ended February 28, | | | Six Months Ended February 28, | |
(In thousands, except per share data) | | 2014 | | | 2013 | | | 2014 | | | 2013 | |
Sales | | $ | 106,107 | | | $ | 110,082 | | | $ | 215,357 | | | $ | 228,104 | |
Cost of sales | | | 93,938 | | | | 99,081 | | | | 192,480 | | | | 203,845 | |
| | | | | | | | | | | | | | | | |
Gross margin | | | 12,169 | | | | 11,001 | | | | 22,877 | | | | 24,259 | |
| | | | |
Operating expenses | | | 7,850 | | | | 7,171 | | | | 15,650 | | | | 14,944 | |
Research and development expenses | | | 1,408 | | | | 1,300 | | | | 2,675 | | | | 2,765 | |
| | | | | | | | | | | | | | | | |
| | | | |
Income from operations | | | 2,911 | | | | 2,530 | | | | 4,552 | | | | 6,550 | |
| | | | |
Interest expense | | | 816 | | | | 983 | | | | 1,630 | | | | 2,064 | |
Other non-operating income (expense), net | | | 6 | | | | 84 | | | | 14 | | | | (79 | ) |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 2,101 | | | | 1,631 | | | | 2,936 | | | | 4,407 | |
| | | | |
Income tax expense | | | 861 | | | | 440 | | | | 1,209 | | | | 1,510 | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 1,240 | | | $ | 1,191 | | | $ | 1,727 | | | $ | 2,897 | |
| | | | | | | | | | | | | | | | |
| | | | |
Weighted average common shares and equivalents outstanding, diluted | | | 12,835 | | | | 12,503 | | | | 12,831 | | | | 12,439 | |
| | | | |
Earnings per common share, diluted | | $ | 0.10 | | | $ | 0.10 | | | $ | 0.13 | | | $ | 0.23 | |
4
Penford Corporation
Reconciliation of Non-GAAP Measure
To supplement the segment and consolidated financial results prepared in accordance with generally accepted accounting principles (“GAAP”), the Company utilizes a non-GAAP financial measure—net income (loss) before interest, taxes, depreciation and amortization expense (“EBITDA”). The Company uses EBITDA to evaluate performance and establish goals. The Company believes that this measure is valuable to investors in assessing the Company’s operating results when viewed in conjunction with GAAP results. This non-GAAP measure is not a substitute for, or an alternative to, the corresponding measure calculated in accordance with GAAP.
Reconciliation of Non-GAAP EBITDA to GAAP Operating Income (Loss)
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended February 28, 2014 | | | Three Months Ended February 28, 2013 | |
| | Food Ingredients | | | Industrial Ingredients | | | Consolidated | | | Food Ingredients | | | Industrial Ingredients | | | Consolidated | |
Operating income (loss) | | $ | 5,794 | | | $ | 14 | | | $ | 2,911 | | | $ | 5,535 | | | $ | (452 | ) | | $ | 2,530 | |
| | | | | | |
Depreciation and amortization | | | 522 | | | | 2,704 | | | | 3,308 | | | | 547 | | | | 2,791 | | | | 3,421 | |
Other non-operating income | | | — | | | | 8 | | | | 6 | | | | — | | | | 3 | | | | 86 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
EBITDA | | $ | 6,316 | | | $ | 2,726 | | | $ | 6,225 | | | $ | 6,082 | | | $ | 2,342 | | | $ | 6,037 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | |
| | Three Months Ended November 30, 2013 | | | | |
| | Food Ingredients | | | Industrial Ingredients | | | Consolidated | | | | | | | | | | |
Operating income (loss) | | $ | 6,530 | | | $ | (2,043 | ) | | $ | 1,641 | | | | | | | | | | | | | |
| | | | | | |
Depreciation and amortization | | | 525 | | | | 2,684 | | | | 3,291 | | | | | | | | | | | | | |
Other non-operating income | | | — | | | | 6 | | | | 8 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
EBITDA | | $ | 7,055 | | | $ | 647 | | | $ | 4,940 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
| | Twelve Months Ended February 28, | | | | | | | | | | | | | |
| | 2014 | | | 2013 | | | | | | | | | | | | | |
Operating income | | $ | 7,406 | | | $ | 10,599 | | | | | | | | | | | | | | | | | |
| | | | | | |
Loss on redemption of Preferred Stock | | | — | | | | (6,599 | ) | | | | | | | | | | | | | | | | |
Depreciation and amortization | | | 13,122 | | | | 13,844 | | | | | | | | | | | | | | | | | |
Other non-operating income | | | 166 | | | | 101 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
EBITDA | | $ | 20,694 | | | $ | 17,945 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
5